Search results for: 'action ingredients for cosmetics'

Non-invasive and minimally invasive procedures for improving the individual’s physical appearance are rapidly gaining traction owing to benefits offered by these procedures such as lower procedure time, minimal discomfort, and shorter recovery period for the patients. The rise in the popularity of these procedures is driving significant innovations...

The study presents an in-depth exploration of novel functional ingredients designed to enhance mental and emotional well-being, identifying the overall drivers of growth, technological change, and market opportunities through 2030. Mental health disorders continue to present a serious global challenge, with anxiety and depression affecting more tha...

The cosmetic and aesthetic procedures market is undergoing a significant transformation, driven by a shift away from invasive surgical interventions toward minimally invasive and non-invasive treatments. Traditional cosmetic surgeries are often associated with higher procedural risks, longer recovery times, and increased costs, whereas emerging tec...

This study provides an overview of the global active pharmaceutical ingredients market. It is broadly divided into three chapters- API market analysis, therapeutic-area wise analysis and recommendations to market participants.

20 Nov 2017  |  North America  |  Market Research

Global Biologics Market—Companies-to-Action

Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

Infographics

×

This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

31 Oct 2017  |  Global  |  Market Research

Global Digital Pathology Market, 2017 Companies-To-Action

Collaborative Business Models Embracing Artificial Intelligence Application in Novel Disease Areas to Drive Market Growth

Infographics

×

It is estimated that more than 19,000 pathologists would be needed to serve the US healthcare needs. However, the actual number is expected to be approximately 40% lesser. Similar trends are foreseen globally driven by aging population and widening application in areas such as cancer diagnostics, drug development, clinical trials, biomarker discove...

The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...

Over the last few decades, modernization-driven lifestyle changes have had major implications on people’s health and well-being. Today, chronic health condition such as cardiovascular diseases (CVD) claim more lives than all forms of cancer combined, accounting for 31% of all deaths worldwide. In the United States alone, 800,000 people succumbed to...

04 Sep 2018  |  North America  |  Market Research

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Infographics

×

Key Issues Addressed

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...